Monoamine Oxidase Inhibitory Potential of Palicourea deflexa Alkaloids Using Zebrafish Model
The genus Palicourea belongs to the Rubiaceae family and it is distributed throughout tropical America. In addition, it is related to Psychotria genus, a well-known source of alkaloids with effects in central nervous system (CNS). Chemically, both genera present monoterpene indole alkaloids (MIAs), especially compounds with a β-carboline (βC) core. Neurodegenerative disorders, such as Parkinson disease (PD) and Alzheimer disease (AD), have a multifactorial etiology. For this reason, the research area of compounds that interact with CNS biotargets, like cholinesterases (AChE and BChE) and monoamine oxidases (MAO-A and MAO-B), is considered a powerful tool in drug design. In this way, modern tools that can increase the success of studies for drug discovery are very important; and the use of alternative animal models as zebrafish (Danio rerio) has been growing recently. Animal models that provide a fast response and high reliability, combining cost / benefit are the key link for the pre-selection of promising entities. In this context, the preset work aimed the optimization an alternative biological model using zebrafish to evaluate the inhibitory potential of monoamine oxidase enzyme of P. deflexa fraction enriched in alkaloids (FEA). The monoamine oxidase enzyme was isolated from zebrafish (zMAO) brain and the protocol described for Holt, 1996 [1] and Anichtchik, 2006 [2] was optimized. In order to carry out the biological tests, P. deflexa was ground and subjected to acid-base extraction with ethyl ether to obtain a FEA. For chemical analysis of FEA, it was developed a method by HPLC/PDA using water:TFA 0,06% and acetonitrile as mobile phases. The protocol for the monoamine oxidase assay was analyzed in a spectrofluorimeter at ʎ = 492 nm and evaluated after 60 min, with previous incubation of tests samples at 28ºC. The zebrafish brain homogenate was prepared by centrifuging at 5000 rpm for 5 min and the supernatant was employed for assay. The chromogenic solution used contain 1 mM of vanillic acid, 500 μM of 4-aminotipyrine and 4U / ml of peroxidase radish tipe II in 0.2 M of potassium phosphate buffer pH 7.6. The assay was performed in 96-well plates containing 21 μL of homogenate (10 mg/mL protein concentration), 50 μL of chromogenic solution, 100 μL of amine substrate at 10mM and the test samples. Chloroglyline - MAO-A inhibitor - (10 nM and 10 μM) and Pargilin - MAO-B inhibitor - (10 nM and 10 μM) were used as positive controls and FEA was tested at different concentrations (10, 50, 100, 250, 500 and 750 μg/mL). Statistical analysis was performed in GraphPad Prism. After the tests, we obtained significant values (p <0.05) for all concentrations tested for P. deflexa FEA and selective inhibitors, either individually or in combination with 10nM and 10 μM of chlorogilin. The P. deflexa FEA showed an inhibition of zMAO of 30.5%; while for chlorogyline at 10nM, the inhibitory potential was 53.9% and for pargyline at 10 μM was equal to 55.5%. Finally, when associated with the two selective inhibitors at 10µM, we obtained an inhibition of 51.6%. In summary, the protocol established using zebrafish as a source of the MAO enzyme can be applied as an important screening tool for natural products. For P. deflexa, the results were promising and a bioguided fractionation is being performed for MAO inhibitors.